ErSO-DFP, is an Activator of the Anticipatory Unfolded Protein Response with Enhanced Selectivity for Estrogen Receptor Positive Breast Cancer. ErSO-DFP maintains antitumor efficacy, has enhanced selectivity for ERα+ cancer cells, and is well tolerated in rodents. ErSO-DFP and related compounds represent an intriguing new class for the treatment of ERα+ cancers.
MedKoo Cat#: 465759
Name: ErSO-DFP
CAS#: unknown
Chemical Formula: C20H17F5N2O2
Exact Mass: 412.1210
Molecular Weight: 412.36
Elemental Analysis: C, 58.25; H, 4.16; F, 23.04; N, 6.79; O, 7.76
The following data is based on the product molecular weight 412.36 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
